Nonetheless, because TS gene expression is known to be an important predictor of outcome for patients with colorectal cancer receiving 5-FU-based therapy, the TS polymorphisms at two sites were included in the initial multivariable model. The gene discussed is TYMS; the disease is colorectal cancer.